These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23516493)

  • 1. NT-proBNP, C-reactive protein and soluble uPAR in a bi-ethnic male population: the SAfrEIC study.
    Kruger R; Schutte R; Huisman HW; Hindersson P; Olsen MH; Eugen-Olsen J; Schutte AE
    PLoS One; 2013; 8(3):e58506. PubMed ID: 23516493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix biomarker, fibulin-1 and its association with soluble uPAR in a bi-ethnic South African population: the SAfrEIC study.
    du Plooy CS; Kruger R; Huisman HW; Rasmussen LM; Eugen-Olsen J; Schutte AE
    Heart Lung Circ; 2015 Mar; 24(3):298-305. PubMed ID: 25456503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-proBNP and potential vascular calcification in Black and Caucasian African men: the SAfrEIC study.
    Kruger R; Schutte R; Huisman HW; Olsen MH; Schutte AE
    Ethn Dis; 2012; 22(4):398-403. PubMed ID: 23140068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix biomarker, fibulin-1, is closely related to NT-proBNP and soluble urokinase plasminogen activator receptor in patients with aortic valve stenosis (the SEAS study).
    Kruger R; Rasmussen LM; Argraves WS; Eugen-Olsen J; Nielsen OW; Blyme A; Willenheimer R; Wachtell K; Olsen MH
    PLoS One; 2014; 9(7):e101522. PubMed ID: 25014213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP is associated with fibulin-1 in Africans: the SAfrEIC study.
    Kruger R; Schutte R; Huisman HW; Argraves WS; Rasmussen LM; Olsen MH; Schutte AE
    Atherosclerosis; 2012 May; 222(1):216-21. PubMed ID: 22349089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex- and age-related differences in the predictive capability of circulating biomarkers: from the MONICA 10 cohort.
    Frary CE; Biering-Sørensen T; Nochioka K; Blicher MK; Olesen TB; Stidsen JV; Greve SV; Vishram-Nielsen JKK; Rasmussen SL; Eugen-Olsen J; Olsen MH; Pareek M
    Scand Cardiovasc J; 2021 Apr; 55(2):65-72. PubMed ID: 33251867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal prohormone B-type natriuretic peptide and cardiovascular function in Africans and Caucasians: the SAfrEIC study.
    Kruger R; Schutte R; Huisman HW; Hindersson P; Olsen MH; Schutte AE
    Heart Lung Circ; 2012 Feb; 21(2):88-95. PubMed ID: 22119736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of suPAR with lifestyle and cardiometabolic risk factors.
    Botha S; Fourie CM; Schutte R; Kruger A; Schutte AE
    Eur J Clin Invest; 2014 Jul; 44(7):619-26. PubMed ID: 24810168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-1 and NT-proBNP in a black and white population: The SABPA study.
    Koegelenberg AS; Smith W; Schutte R; Schutte AE
    Eur J Clin Invest; 2016 Sep; 46(9):795-803. PubMed ID: 27455178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: the SAfrEIC-study.
    Schutte AE; Myburgh A; Olsen MH; Eugen-Olsen J; Schutte R
    Thromb Res; 2012 Aug; 130(2):273-7. PubMed ID: 22113150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort.
    Frary CE; Blicher MK; Olesen TB; Stidsen JV; Greve SV; Vishram-Nielsen JK; Rasmussen SL; Olsen MH; Pareek M
    Eur J Prev Cardiol; 2020 Apr; 27(6):570-578. PubMed ID: 31718257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.
    Saxena A; Izmirly PM; Han SW; Briassouli P; Rivera TL; Zhong H; Friedman DM; Clancy RM; Buyon JP
    J Am Coll Cardiol; 2015 Aug; 66(8):930-9. PubMed ID: 26293764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble urokinase plasminogen activator receptor as a prognostic marker of all-cause and cardiovascular mortality in a black population.
    Botha S; Fourie CMT; Schutte R; Eugen-Olsen J; Pretorius R; Schutte AE
    Int J Cardiol; 2015 Apr; 184():631-636. PubMed ID: 25771228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term pronostic value of suPAR in chronic heart failure: reclassification of patients with low MAGGIC score.
    Dupuy AM; Kuster N; Bargnoux AS; Aguilhon S; Huet F; Leclercq F; Pasquié JL; Roubille F; Cristol JP
    Clin Chem Lab Med; 2021 Jun; 59(7):1299-1306. PubMed ID: 33544524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation.
    Borné Y; Persson M; Melander O; Smith JG; Engström G
    Eur J Heart Fail; 2014 Apr; 16(4):377-83. PubMed ID: 24464777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NT-proBNP and metabolic risk factors in a bi-ethnic cohort: the Ambulatory Blood Pressure in African prospective cohort study.
    Jujić A; Melander O; Nilsson PM; Malan L; Fedorowski A; Magnusson M
    Cardiovasc J Afr; 2020; 31(6):291-297. PubMed ID: 33180090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of N-terminal pro-B-type natriuretic peptide and related inflammatory biomarkers on periodontal treatment outcomes in patients with periodontitis: An explorative human randomized-controlled clinical trial.
    Isola G; Tartaglia GM; Santonocito S; Polizzi A; Williams RC; Iorio-Siciliano V
    J Periodontol; 2023 Dec; 94(12):1414-1424. PubMed ID: 37433155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperpulsatile pressure, systemic inflammation and cardiac stress are associated with cardiac wall remodeling in an African male cohort: the SABPA study.
    van Vuren EJ; Malan L; von Känel R; Cockeran M; Malan NT
    Hypertens Res; 2016 Sep; 39(9):648-53. PubMed ID: 27169396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study.
    Bruno G; Landi A; Barutta F; Ghezzo G; Baldin C; Spadafora L; Schimmenti A; Prinzis T; Cavallo Perin P; Gruden G
    Diabetes Care; 2013 Sep; 36(9):2677-82. PubMed ID: 23564918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble urokinase plasminogen activator receptor and survival in elective cardiac surgery.
    Koller L; Steinacher E; Hofer F; Hammer A; Kazem N; Laufer G; Fleck T; Steinlechner B; Wojta J; Richter B; Hengstenberg C; Sulzgruber P; Niessner A
    Eur J Clin Invest; 2023 May; 53(5):e13953. PubMed ID: 36656688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.